GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Suisse Corp (OTCPK:CSUI) » Definitions » DeferredTaxAndRevenue

Switch to:

Cannabis Suisse (Cannabis Suisse) DeferredTaxAndRevenue : $0.00 Mil (As of Feb. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cannabis Suisse DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Cannabis Suisse's current deferred tax and revenue for the quarter that ended in Feb. 2024 was $0.00 Mil.

Cannabis Suisse DeferredTaxAndRevenue Historical Data

The historical data trend for Cannabis Suisse's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Suisse DeferredTaxAndRevenue Chart

Cannabis Suisse Annual Data

Trend

May16

May17

May18

May19

May20

May21

May22

May23

DeferredTaxAndRevenue

Get a 7-Day Free Trial

-

-

-

-

-

Cannabis Suisse Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
DeferredTaxAndRevenue	Get a 7-Day Free Trial															-	-	-	-	-

Cannabis Suisse DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Cannabis Suisse's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Suisse (Cannabis Suisse) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Suisse Corp (OTCPK:CSUI) » Definitions » DeferredTaxAndRevenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 North Neuman Street, Suite A, Jacksonville, FL, USA, 32202

Website

https://www.cannabissuisse.com

Cannabis Suisse Corp is engaged in the rental of commercial office and industrial space.

Executives

Scott Walker Mcalister

director, 10 percent owner, officer: CEO/CFO

10 NORTH NEWNAN STREET, SUITE A, JACKSONVILLE FL 32202

Cannabis Suisse (Cannabis Suisse) Headlines

From GuruFocus

Cannabis Suisse Corp. has sent its first shipment to ACS Laboratory for CBD potency testing

By ACCESSWIRE ACCESSWIRE • 01-19-2021

Cannabis Suisse Corp. announces the next product TerpX2 for its new Swiss4Life CBD Brand

By ACCESSWIRE ACCESSWIRE • 10-28-2020

Cannabis Suisse is Releasing its New Service "Your Cannabis Grow" to the European Market

By ACCESSWIRE ACCESSWIRE • 08-13-2020

Cannabis Suisse Corp. announces its decision to work with ACS Laboratory to test its first shipment of Swiss4Life products

By ACCESSWIRE ACCESSWIRE • 12-02-2020

Cannabis Suisse Corp. Retains FDA Registered Silver Shadow Ventures, LLC to Manufacture New High Quality CBD Brand of products

By ACCESSWIRE ACCESSWIRE • 10-07-2020

Cannabis Suisse Corp. Continues Expanding its Horizons in The Field of Online Sales With Shopify as Next Planned Launch

By ACCESSWIRE ACCESSWIRE • 10-01-2020

Cannabis Suisse Corp. Expansion Plans for Online Sales, Adding to CBD product lines with New Hemp Brands

By ACCESSWIRE ACCESSWIRE • 09-21-2020

Cannabis Suisse Corp. Announces the Commencement of Development of the New IT Product "Cannabis Life"

By ACCESSWIRE ACCESSWIRE • 10-29-2021

Cannabis Suisse Corp. Reports on Developing its Website

By ACCESSWIRE ACCESSWIRE • 06-15-2021

Cannabis Suisse Corp. Announces Distribution Negotiations with uWeed

By ACCESSWIRE ACCESSWIRE • 08-25-2020

Home About Jobs Site Map Term of Use Privacy Policy Mobile App Referral Program Partner Program FAQ Contact Us 中文 All-In-One Screener
Stock List Guru List Insider List Insider Trade Economic Indicators Industry Data DCF Calculator Discussion Board Plans Excel Add-In Google Sheets Add-on
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.